Comparison of 16 Serological SARS-CoV-2 Immunoassays in 16 Clinical Laboratories-Reference-Cited by-同舟云学术

Comparison of 16 Serological SARS-CoV-2 Immunoassays in 16 Clinical Laboratories

Published:2021-04-20 Issue:5 Volume:59 Page:
ISSN:0095-1137
Container-title:Journal of Clinical Microbiology
language:en
Short-container-title:J Clin Microbiol

Author:

Harritshøj Lene H.¹^ORCID,Gybel-Brask Mikkel¹^ORCID,Afzal Shoaib²³,Kamstrup Pia R.²,Jørgensen Charlotte S.⁴,Thomsen Marianne Kragh⁵,Hilsted Linda⁶,Friis-Hansen Lennart⁷,Szecsi Pal B.⁸,Pedersen Lise⁸,Nielsen Lene⁹,Hansen Cecilie B.¹⁰,Garred Peter¹⁰¹¹,Korsholm Trine-Line¹²,Mikkelsen Susan¹²,Nielsen Kirstine O.¹²,Møller Bjarne K.¹²,Hansen Anne T.¹,Iversen Kasper K.¹³¹⁴,Nielsen Pernille B.¹³¹⁴,Hasselbalch Rasmus B.¹³¹⁴,Fogh Kamille¹³¹⁴,Norsk Jakob B.¹³¹⁴,Kristensen Jonas Henrik¹³¹⁴,Schønning Kristian¹⁵^ORCID,Kirkby Nikolai S.¹⁵,Nielsen Alex C. Y.¹⁵,Landsy Lone H.¹⁶,Loftager Mette¹⁶,Holm Dorte K.¹⁷,Nilsson Anna C.¹⁷,Sækmose Susanne G.¹⁸,Grum-Schwensen Birgitte¹⁸,Aagaard Bitten¹⁹,Jensen Thøger G.²⁰²¹,Nielsen Dorte M.²²,Ullum Henrik¹¹¹²³,Dessau Ram B.²²^ORCID

Affiliation:

1. Department of Clinical Immunology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark

2. Department of Clinical Biochemistry, Copenhagen University Hospital, Herlev and Gentofte Hospital, Herlev, Denmark

3. Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark

4. Department of Virus & Microbiological Special Diagnostics, Statens Serum Institut, Copenhagen, Denmark

5. Department of Clinical Microbiology, Aarhus University Hospital, Aarhus, Denmark

6. Department of Clinical Biochemistry, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark

7. Department of Clinical Biochemistry, Copenhagen University Hospital, Bispebjerg, and Frederiksberg Hospital, Copenhagen, Denmark

8. Department of Clinical Biochemistry, Holbæk Hospital, Holbæk, Denmark

9. Department of Clinical Microbiology, Copenhagen University Hospital, Herlev and Gentofte Hospital, Copenhagen, Denmark

10. Laboratory of Molecular Medicine, Department of Clinical Immunology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark

11. Department of Clinical Medicine, Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark

12. Department of Clinical Immunology, Aarhus University Hospital, Aarhus, Denmark

13. Department of Cardiology, Herlev og Gentofte Hospital, University of Copenhagen, Herlev, Denmark

14. Department of Emergency Medicine, Herlev og Gentofte Hospital, University of Copenhagen, Herlev, Denmark

15. Department of Clinical Microbiology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark

16. Department of Nonclinical and Clinical Assay Sciences in Global Discovery & Development Sciences, Novo Nordisk A/S, Måløv, Denmark

17. Department of Clinical Immunology, Odense University Hospital, Odense, Denmark

18. Department of Clinical Immunology, Zealand University Hospital, Næstved Hospital, Næstved, Denmark

19. Department of Clinical Immunology, Aalborg University Hospital, Aalborg, Denmark

20. Department of Clinical Microbiology, Odense University Hospital, Odense, Denmark

21. Research Unit for Clinical Microbiology, Odense University Hospital, University of Southern Denmark, Odense, Denmark

22. Department of Clinical Microbiology, Zealand University Hospital, Slagelse Hospital, Slagelse, Denmark

23. Statens Serum Institut, Copenhagen, Denmark

Abstract

Serological assays for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are needed to support clinical diagnosis and epidemiological investigations. Recently, assays for large-scale detection of total antibodies (Ab), immunoglobulin G (IgG), and IgM against SARS-CoV-2 antigens have been developed, but there are limited data on the diagnostic accuracy of these assays.

Publisher

American Society for Microbiology

Subject

Microbiology (medical)

Link

https://journals.asm.org/doi/pdf/10.1128/JCM.02596-20

Reference31 articles.

1. Ghebreyesus T. 2020. WHO Director-General's opening remarks at the media briefing on COVID-19—11 March 2020.

2. SARS-CoV-2 and Coronavirus Disease 2019: What We Know So Far

3. Immune responses in COVID-19 and potential vaccines: Lessons learned from SARS and MERS epidemic

4. Antibody tests for identification of current and past infection with SARS-CoV-2

5. The Role of Antibody Testing for SARS-CoV-2: Is There One?

Cited by 109 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Robust immune response to COVID-19 vaccination in the island population of Greenland;Communications Medicine;2024-09-06

2. Production of antigens expressed in Nicotiana benthamiana plant and Escherichia coli for the SARS-CoV-2 IgG antibody detection by ELISA;Journal of Virological Methods;2024-09

3. COVID‐19 Vaccination Before Initiating Rituximab Treatment Induces Strong Serological Response in Autoimmune Rheumatic Disease, Reducing Post‐Pandemic Concerns About the Impact of Rituximab;ACR Open Rheumatology;2024-06-23

4. High SARS-CoV-2 infection rate in children unvaccinated with COVID-19 vaccine in Changzhou, China, shortly after lifting zero-COVID-19 policy in December 2022;BMC Infectious Diseases;2024-06-05

5. Antibody status at delivery and pregnancy outcomes during the first Danish COVID-19 wave;Danish Medical Journal;2024-06-01